Skip to main content

Peer Review reports

From: Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION

Original Submission
23 Jun 2022 Submitted Original manuscript
11 Jul 2022 Reviewed Reviewer Report - Riaz Qureshi
22 Jul 2022 Author responded Author comments - Jan Andreas Kloka
Resubmission - Version 2
22 Jul 2022 Submitted Manuscript version 2
29 Jul 2022 Reviewed Reviewer Report - Riaz Qureshi
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
29 Jul 2022 Editorially accepted
19 Aug 2022 Article published 10.1186/s13063-022-06609-x

You can find further information about peer review here.

Back to article page